Table 1 Baseline characteristic of patients underwent SG or GB bariatric surgery
|  | SG (n = 2202) | GB (n = 1085) | P-value |
|---|---|---|---|
Sex female, | 1683 (76.4) | 903 (83.2) | < 0.001 |
Age, year, | 38.0 ± 11.8 | 39.4 ± 10.7 | .002 |
Age groups, n (%) | Â | Â | 0.001 |
  < 40 | 1264 (57.8) | 561 (51.9) |  |
  ≥ 40 | 922 (42.2%) | 519 (48.1%) |  |
Fat mass | 59.7 ± 11.6 | 60.7 ± 11.6 | 0.020 |
Fat percent | 49.6 ± 4.8 | 50.1 ± 4.8 | 0.004 |
Smoking status | Â | Â | .031 |
 Never smokers | 1808 (87.2) | 916 (90.4) |  |
 Current smokers | 164 (7.9) | 59 (5.8) |  |
Anthropometric indices | |||
BMI, kg/m2 | 44.6 ± 5.7 | 45.5 ± 6.1 | < 0.001 |
BMI groups |  |  | < 0.001 |
 BMI < 45 kg/m2 | 1306 (59.6) | 557 (51.4) |  |
 BMI ≥45 kg/m2 | 885 (40.4) | 526 (48.6) |  |
Weight, kg | 121.0 ± 21.0 | 121.4 ± 20.0 | .596 |
Height, cm | 164.5 ± 9.4 | 163.1 ± 8.8 | < 0.001 |
Waist circumference, cm | 123.2 ± 15.1 | 124.3 ± 14.3 | .061 |
Metabolic indices | |||
 SBP (mmHg) | 123.6 ± 12.9 | 123.4 ± 12.1 | .776 |
 DBP (mmHg) | 79.7 ± 8.1 | 79.4 ± 7.4 | .207 |
 FPG (mg/dL) | 105.8 ± 28.5 | 117.9 ± 49.9 | < 0.001 |
 HbA1c% | 5.5 (5.1–6.0) | 5.6 (5.2–6.4) | < 0.001 |
 Triglyceride, mg/dL | 140 (103–187) | 143 (107–195) | .103 |
 HDL, mg/dL | 47.4 ± 12.0 | 47.0 ± 11.3 | .423 |
 LDL, mg/dL | 112.3 ± 31.5 | 109.5 ± 32.2 | .023 |
 Total cholesterol, mg/dL | 190.8 ± 37.7 | 189.4 ± 39.6 | .370 |
 Creatinine, mg/dL | .92 ± .39 | .92 ± .41 | .899 |
 AST (U/L) | 23.3 ± 13.6 | 22.9 ± 13.7 | .452 |
 ALT (U/L) | 31.1 ± 23.1 | 29.8 ± 24.2 | .121 |
Medication | |||
 Insulin | 31 (8.7) | 69 (22.9) | < 0.001 |
 Oral glycemic medicines | 206 (58.1) | 175 (58.2) | .329 |
 Dyslipidemia medicines | 448 (20.3) | 307 (28.3) | < 0.001 |
 Blood pressure medicines | 469 (21.3) | 278 (25.6) | .006 |
Comorbidities | |||
 Diabetes | 493 (24.1) | 376 (35.9) | < 0.001 |
 Hypertension | 622 (30.2) | 329 (32.0) | .321 |
 Dyslipidemia | 1820 (85.5) | 926 (87.0) | .256 |